Matthew Davis is the senior director of medical affairs at surgenex, USA, where he provides scientific leadership in regenerative medicine and human cellular and tissue-based technologies. With over two decades of healthcare experience, he has worked extensively in clinical education, biologic therapies, and evidence-based regenerative approaches that support tissue repair and skin restoration. His professional interests include regenerative aesthetics, advanced wound healing, tissue engineering, and the clinical application of biologic products in reconstructive and aesthetic medicine. Through collaborations with physicians, surgeons, and researchers, he contributes to advancing innovative therapies that bridge regenerative science and modern skin care, promoting improved patient outcomes and clinical best practices.

Matthew Davis's research interests focus on regenerative medicine and its applications in skin and soft tissue repair, with particular emphasis on biologic therapies, human cellular and tissue-based products, and tissue engineering. His work explores innovative approaches to wound healing, regenerative aesthetics, and reconstructive medicine, supporting evidence-based strategies that enhance tissue regeneration and improve clinical outcomes. He is also interested in the translation of emerging regenerative technologies into clinical practice, interdisciplinary collaboration, and the advancement of medical education and research in skin restoration and aesthetic healthcare.